Bone and mineral disorders occur frequently in kidney transplant recipients and are
associated with a high risk of fracture, morbidity, and mortality. There is a broad spectrum of …

End-stage renal disease is often complicated by the occurrence of secondary and eventually
tertiary hyperparathyroidism, characterized by increased parathormone, calcium, and …

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) comprises alterations in
calcium, phosphorus, parathyroid hormone (PTH), Vitamin D, and fibroblast growth factor-23 …

Background Tertiary hyperparathyroidism after kidney transplantation has been associated
with graft dysfunction, cardiovascular morbidity, and osteopenia; however, its true …

After kidney transplantation, mineral and bone disorders are associated with higher risk of
fractures and consequent morbidity and mortality. Disorders of calcium and phosphorus …

Chronic kidney disease (CKD) is associated with a higher prevalence of vascular
calcification (VC) and cardiovascular disease. VC in CKD patients showed different …

Background and aims The purpose of this review is to provide updated recommendations for
the surgical management of primary (pHPT) and renal (rHPT) hyperparathyroidism …

Background Renal transplant allograft function in patients with tertiary hyperparathyroidism
who are treated with cinacalcet versus parathyroidectomy remains unclear. Methods This is …

Chronic kidney disease mineral and bone disorder may persist after successful kidney
transplantation. Persistent hyperparathyroidism has been identified in up to 80% of patients …

Objective Osteoporosis and fragility fractures represent serious complications for the solid
organ transplant population. The recommended osteoporosis therapy for organ recipients …